Cutler Group LP Horizon Therapeutics Public LTD CO Call Options Transaction History

Cutler Group LP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 07, 2023	SELL	$98.98 - $115.74 $2.34 Million - $2.73 Million	-23,600 Reduced 93.65%	1,600 $14,000
Q2 2023 Jul 18, 2023	BUY	$96.34 - $112.38 $2.39 Million - $2.79 Million	24,800 Added 6200.0%	25,200 $80,000
Q1 2023 May 01, 2023	SELL	$107.32 - $113.5 $3.96 Million - $4.19 Million	-36,900 Reduced 98.93%	400 $3,000
Q4 2022 Feb 07, 2023	BUY	$62.39 - $113.8 $2.3 Million - $4.19 Million	36,800 Added 7360.0%	37,300 $217,000
Q3 2022 Oct 25, 2022	SELL	$58.92 - $84.67 $23,568 - $33,868	-400 Reduced 44.44%	500 $1,000

Q2 2022 Aug 04, 2022	SELL	$79.4 - $116.36 $2.41 Million - $3.53 Million	-30,300 Reduced 97.12%	900 $0
Q1 2022 Apr 14, 2022	BUY	$86.42 - $109.81 $2.63 Million - $3.34 Million	30,400 Added 3800.0%	31,200 $206,000
Q4 2021 Jan 18, 2022	SELL	$98.56 - $119.91 $551,936 - $671,496	-5,600 Reduced 87.5%	800 $34,000
Q3 2021 Oct 26, 2021	BUY	$91.91 - $110.37 $82,719 - $99,333	900 Added 16.36%	6,400 $11,000
Q1 2021 Apr 26, 2021	BUY	$71.83 - $95.48 $323,235 - $429,660	4,500 Added 450.0%	5,500 $19,000
Q4 2020 Jan 21, 2021	SELL	$67.0 - $84.39 $13,400 - $16,878	-200 Reduced 16.67%	1,000 $2,000
Q2 2020 Jul 22, 2020	BUY	$30.2 - $56.98 $36,240 - $68,376	1,200 New	1,200 $9,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.